Interferon Inducer IFI35 Regulates RIG-I-Mediated Innate Antiviral Response through Mutual Antagonism with Influenza Virus Protein NS1

Hui Yang,Wendy Winkler,Xiaopeng Wu
DOI: https://doi.org/10.1128/jvi.00283-21
IF: 6.549
2021-05-10
Journal of Virology
Abstract:Influenza A virus (IAV) infection poses a global health threat and is among the most common contagious pathogens to cause severe respiratory infections in humans and animals. ISGs play a key role in host defense against IAV infection.
virology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how interferon - inducible protein 35 (IFI35) regulates the RIG - I - mediated innate antiviral response through the mutual antagonistic interaction with the influenza virus protein NS1. Specifically, the researchers hope to understand how IFI35 interacts with the NS1 proteins of different subtypes of influenza viruses (such as H3N2 and H7N9), and how this interaction affects the host's antiviral immune response, especially the RIG - I - mediated type I interferon (IFN) signaling pathway. The study found that IFI35 can directly interact with the NS1 protein of swine influenza virus (H3N2), but does not interact with the NS1 protein of avian influenza virus (H7N9). This selective interaction leads to functional differences of IFI35 in different influenza virus infections. For H3N2 infection, IFI35 inhibits virus replication through its interaction with NS1; while for H7N9 infection, due to the lack of interaction with NS1, IFI35 instead promotes virus replication. In addition, the study also revealed that IFI35 negatively regulates the stability of RIG - I by promoting K48 - linked ubiquitination and degradation of RIG - I, and NS1 - H3N2 can competitively bind to IFI35, thereby relieving the inhibitory effect of IFI35 on RIG - I and enhancing the host's antiviral immune response. In summary, this study provides a new mechanism, explaining how IFI35 regulates the RIG - I - mediated antiviral immune response through the mutual antagonistic interaction with the influenza virus NS1 protein, which provides new ideas for the development of anti - influenza virus treatment strategies.